skin barrier
Explore 2 research publications tagged with this keyword
Publications Tagged with "skin barrier"
2 publications found
2026
1 publicationFORMULATION AND EVALUATION OF FACIAL CLAY CLEANSERS BY USING ZINC PCA AND KAOLIN CLAY
Background: Facial cleansers remove excess oil and impurities while maintaining skin comfort. Zinc PCA was selected for its sebum-regulating properties, and kaolin clay was used as an adsorbent. Objective: To formulate and evaluate eight clay-based facial cleansers containing Zinc PCA and kaolin clay using xanthan gum or guar gum as thickening agents. Methods: The formulations (F1–F8) were prepared using a simple mixing method. Zinc PCA (0.5%), kaolin clay (5%), glycerin (10%), disodium EDTA (0.3%), cocamidopropyl betaine (6%), and sodium benzoate (0.5%) were kept constant. Xanthan gum concentrations ranged from 0.2% to 0.5% in F1–F4, while guar gum concentrations ranged from 0.4% to 0.7% in F5–F8. The formulations were evaluated for FTIR compatibility, appearance, homogeneity, pH, viscosity, spreadability, washability, phase separation, and foam height. Results: All formulations appeared milky, cloudy, and off-white, with visual homogeneity. The pH ranged from 5.16 to 5.51, viscosity from 260 to 2100 mPa·s, and foam height from 1.40 to 4.53 cm. Spreadability values ranged from 220.8 to 528.57 g·cm/s. No phase separation was observed in F1–F4, whereas F5–F8 showed separation. F2 and F7 were identified as preferred candidates based on the overall evaluation. Conclusion: Zinc PCA–kaolin clay facial cleansers were successfully formulated. However, guar-gum formulations require further optimization to improve stability. Long-term stability, safety, and efficacy studies are necessary before confirming their skin benefits. Keywords: sebum regulation; skin barrier; adsorbent; xanthan gum; guar gum
2025
1 publicationRecent Advances in Transdermal Drug Delivery Systems: Emerging Technologies and Future Perspectives
Transdermal drug delivery systems (TDDS), particularly in the form of patches, have emerged as a major breakthrough in pharmaceutical science, enabling drugs to be administered directly through the skin in a non-invasive manner. These systems allow controlled and sustained drug release, leading to improved therapeutic efficiency. Unlike conventional oral route Skin, TDDS bypass first-pass metabolism and help maintain consistent plasma drug concentrations. Progress in this field has been driven by the development of innovative materials, novel polymers, advanced permeation enhancers, and smart delivery platforms. The incorporation of nanotechnology has broadened the applicability of TDDS, making it possible to deliver molecules that were previously unsuitable for transdermal administration. Deeper understanding of skin physiology and its barrier functions has facilitated the design of next-generation patches utilizing nanocarriers, microemulsions, and stimuli-responsive polymers. Additionally, approaches such as microneedle arrays, iontophoresis, and sonophoresis have significantly boosted drug permeation across the skin. Several marketed products highlight the practical success of these technologies, while ongoing research continues to refine delivery strategies and evaluation techniques. Overall, the evolution of TDDS has led to more effective, convenient, and patient-friendly therapeutic options, positioning them as a promising platform for addressing complex treatment challenges and catering to diverse healthcare needs in the future.
